Related Experiment Video
Updated: Nov 30, 2025

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
Published on: July 5, 2024
Identifying RNA Helicase Inhibitors Using Duplex Unwinding Assays
John C Marecki1, Alicia K Byrd1, Kevin D Raney2
1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
RNA helicases are crucial for RNA metabolism and are targets for disease treatment. High-throughput screening assays are optimized to discover specific RNA helicase inhibitors, overcoming challenges in targeting these enzymes.
Area of Science:
- Biochemistry and Molecular Biology
- Enzymology
- Drug Discovery
Background:
- RNA helicases are essential enzymes involved in nearly all aspects of RNA metabolism.
- Pathogenic viruses and bacteria utilize their own RNA helicases, making them attractive therapeutic targets.
- Structural similarities across RNA helicase families pose challenges for developing specific inhibitors.
Purpose of the Study:
- To develop rapid screening approaches for identifying modulators of RNA helicase activity.
- To enable the discovery of specific inhibitors targeting RNA helicases for therapeutic purposes.
Main Methods:
- Optimization and adaptation of standard helicase assays for high-throughput screening (HTS).
- Implementation of medium to high-throughput methodologies for inhibitor screening.
- Detailed protocol development for reproducible HTS of RNA helicase modulators.
Main Results:
- Successful adaptation of helicase assays to high-throughput modalities.
- Demonstration of the utility of optimized assays for rapid screening.
- Establishment of protocols for efficient inhibitor discovery targeting RNA helicases.
Conclusions:
- High-throughput screening assays are effective for discovering RNA helicase inhibitors.
- Optimized assays provide a viable strategy to overcome challenges in targeting conserved helicase structures.
- This approach facilitates the development of novel therapeutics by targeting essential viral and bacterial RNA helicases.
More Related Videos
06:10A Fluorescence-based Exonuclease Assay to Characterize DmWRNexo, Orthologue of Human Progeroid WRN Exonuclease, and Its Application to Other Nucleases
Published on: December 23, 2013
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019